Clinical Trial Update: Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx IGH Assay

View source ↗

Summary

Pivotal clinical study update evaluating the accuracy of Invivoscribe's IdentiClone Dx IGH Assay for B-cell lymphoproliferative disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoproliferative Disorder

Drugs mentioned

• IdentiClone Dx IGH Assay

Snippet

Sponsor: Invivoscribe, Inc. | Conditions: B-Cell Lymphoproliferative Disorder | Status: COMPLETED